You are here:

  1. Home
  2. NICE Guidance
  3. Published Guidance

Sunitinib for the treatment of gastrointestinal stromal tumours

  • Technology appraisal guidance
  • Reference number: TA179
  • Published:  23 September 2009
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Recommendations for further research
  • 7 Appraisal committee members and NICE project team
  • 8 Sources of evidence considered by the committee
  • Update information

6 Recommendations for further research

6.1

A trial comparing 37.5 mg sunitinib with 800 mg imatinib is currently recruiting participants.

6.2

The committee considered that rigorous data collection is needed on the life-extending benefits of sunitinib.


Next page 7 Appraisal committee members and NICE project team Previous page 5 Implementation
Back to top